Wells Fargo
GOSS icon

Wells Fargo’s Gossamer Bio GOSS Stock Holding History

Wells Fargo’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07K Sell
81
-872
-92% -$19.5K ﹤0.01% 6454
2026
Q1 		$25.1K Sell
953
-3,571
-79% -$449K ﹤0.01% 5694
2025
Q4 		$1.12M Buy
4,524
+3,066
+210% +$700K ﹤0.01% 3878
2025
Q3 		$307K Buy
1,458
+231
+19% +$40.7K ﹤0.01% 4664
2025
Q2 		$121K Buy
1,227
+1,172
+2,131% +$102K ﹤0.01% 5088
2025
Q1 		$4.85K Buy
+55
New +$5.09K ﹤0.01% 6035
2024
Q4 		– Sell
-3
Closed -$260 – 7115
2024
Q3 		$260 Sell
3
-2
-40% -$154 ﹤0.01% 6214
2024
Q2 		$360 Sell
5
-20
-80% -$1.2K ﹤0.01% 6169
2024
Q1 		$2.32K Buy
25
+1
+4% +$88 ﹤0.01% 6005
2023
Q4 		$1.77K Buy
24
+1
+4% +$59 ﹤0.01% 6121
2023
Q3 		$1.55K Buy
23
+11
+92% +$1.01K ﹤0.01% 6132
2023
Q2 		$1.16K Sell
12
-146
-92% -$14.5K ﹤0.01% 6293
2023
Q1 		$16K Buy
+158
New +$24.2K ﹤0.01% 5713
2022
Q4 		– Sell
-42
Closed -$39K – 7561
2022
Q3 		$39K Sell
42
-5
-11% -$4.96K ﹤0.01% 5064
2022
Q2 		$31K Sell
47
-40
-46% -$24.8K ﹤0.01% 5250
2022
Q1 		$60K Sell
87
-266
-75% -$205K ﹤0.01% 5564
2021
Q4 		$319K Buy
353
+157
+80% +$149K ﹤0.01% 5005
2021
Q3 		$198K Buy
196
+2
+1% +$1.47K ﹤0.01% 5100
2021
Q2 		$126K Sell
194
-52
-21% -$36.1K ﹤0.01% 5210
2021
Q1 		$182K Sell
246
-479
-66% -$386K ﹤0.01% 5199
2020
Q4 		$560K Buy
725
+223
+44% +$176K ﹤0.01% 4438
2020
Q3 		$497K Sell
502
-191
-28% -$203K ﹤0.01% 4341
2020
Q2 		$721K Buy
693
+163
+31% +$164K ﹤0.01% 4068
2020
Q1 		$430K Buy
530
+227
+75% +$237K ﹤0.01% 4153
2019
Q4 		$380K Sell
303
-2
-0.7% -$3.22K ﹤0.01% 4571
2019
Q3 		$409K Sell
305
-15
-5% -$23.9K ﹤0.01% 4506
2019
Q2 		$568K Buy
320
+247
+338% +$378K ﹤0.01% 4287
2019
Q1 		$126K Buy
+73
New +$122K ﹤0.01% 5051

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Wells Fargo's GOSS Position: Q2 2026 in Review

Wells Fargo reduced its Gossamer Bio (GOSS) stake by 92% in Q2 2026, selling an estimated $19.5K and leaving 81 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #6454.

Wells Fargo first reported a position in GOSS in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.12M in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Wells Fargo held 81 shares of Gossamer Bio worth $1.07K as of Q2 2026.
  • Wells Fargo sold 872 Gossamer Bio shares in Q2 2026, an estimated $19.5K.
  • Gossamer Bio made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6454 holding.
  • Wells Fargo first reported a position in Gossamer Bio in Q1 2019 and has held it in 28 quarters since.
  • Wells Fargo's Gossamer Bio position peaked at $1.12M in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.